MOH — authorised 2 March 2021
- Marketing authorisation holder: COMMCAVE THERAPEUTICS SA
- Status: likely_approved
MOH authorised Azstarys on 2 March 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 2 March 2021.
COMMCAVE THERAPEUTICS SA holds the Israeli marketing authorisation.